Skip to main content
. 2004 Jun 8;91(1):186–192. doi: 10.1038/sj.bjc.6601909

Table 2. Percentage Philadelphia chromosome positive colonies (CFU-GM) in patients with CML in the presence or absence of 8Cl-cAMP.

  Week 0
Week 5
Patient ID Control 8Cl-cAMP 50 μm 8Cl-cAMP 100 μm Control 8Cl-cAMP 50 μm 8Cl-cAMP 100 μm
1216 (cp) 100 (2/2) 100 (20/20) 100 (28/28) ND 14 (3/21) 0 (0/15)
1206 (cp) 100 (12/12) ND 70 (12/17) 83 (30/36) ND 0 (0/15)
1726 (cp) 100 (62/62) ND 100 (25/25) 83 (26/29) ND 0 (0/37)
166 (D) 100 (6/6) 100 (15/15) ND 100 (20/20) 46 (7/15) ND
A97/3 (ap) 100 (21/21) ND 100 (30/30) 100 (5/5) ND 83 (5/6)
371 (ap) 81 (27/33) ND 92 (24/26) 81 (27/33) ND 33 (1/3)
361 (ap) 100 (30/30) ND 100 (19/19) 100 (30/30) ND 50 (2/4)
341 (ap) 100 (40/40) ND 96 (26/27) 100 (34/34) ND 62 (5/8)

The Ph1 chromosome positive colonies (in %) arising from patient bone marrow cells in percent are summarised, the actual number of colonies is given in parenthesis (Ph1 chromosome+/total number). MNC were incubated for 24 h without or with 50 or 100 μm of 8-Cl-cAMP as indicated, washed and resuspended in long-term culture medium (Dexter). CFU-assays were setup in week 0 and weekly thereafter. CFU-GM of the adherent fraction of the cells (ADC) is shown, since there were only few colonies in the non-adherent fraction at this time. Ph1 chromosome status was determined by cytogenetic analysis. cp=chronic phase; D=diagnosis; ap=accelerated phase; ND=not determined.